33P Changes in serum cytokine CXCL12 level can predict the survival of patients with non-small cell lung cancer receiving anti-PD-1 treatment

Y. Xu,H. Li, Z. Huang, M. Xie,Z. Zhou, Y. Fan

Immuno-Oncology and Technology（2022）

引用 0|浏览2

暂无评分

摘要

The circulating predictive factors for survival of advanced non-small-cell lung cancer (NSCLC) patients receiving immune checkpoint inhibitors (ICIs) remain elusive. We aimed to identify the predictive value of circulating cytokines and programmed cell death ligand-1 (PD-L1) expression for survival.

查看译文

关键词

lung cancer,serum cytokine,non-small

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要